Suzuki I am in the medical business for 40 years . Mitral valvular disease is a huge area but its a very complex valve. Edwards are spending big in this area as its the new frontier of expansion.Anteris are in bed with 4C but they had a problem or two but the concept of their valve was novel and exciting. All I was stating is that our best in class Adapt tissue will be a big winner for the future successful Mitral valve company. If WP sells the company in toto I would like that he takes the value of our adapt tissue for the mitral valve area into account and claim an extra $1b for shares holders.
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve, page-113
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.80 |
Change
-0.200(1.67%) |
Mkt cap ! $249.4M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.99 | $11.63 | $303.4K | 24.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1100 | $11.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.15 | 849 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |